🇺🇸 FDA
Patent

US 8187872

Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein

granted A61KA61K2039/5256A61K2239/50

Quick answer

US patent 8187872 (Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein) held by IMMUNE DESIGN CORP. expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
IMMUNE DESIGN CORP.
Grant date
Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/5256, A61K2239/50, A61K39/0011, A61K39/001154